Showing results (21-30 of 50) with videos related to
Sort By:
Pageof 5
American Journal of Hematology|November 15, 2011
The potential role of pre-transplant HBcIgG seroposivity as predictor of clinically relevant cytomegalovirus infection in patients with lymphoma undergoing autologous hematopoietic stem cell transplantation: a study from the Rome Transplant NetworkFrancesco Marchesi, Federica Giannotti, Giuseppe Avvisati, et al.Cancers|September 28, 2024
Response Rates and Transplantation Impact in Patients with Relapsed Acute Promyelocytic LeukemiaAlessandro Costa, Carmelo Gurnari, Emilia Scalzulli, et al.Current Research in Translational Medicine|May 8, 2024
Fatal acute graft-versus-host disease in Sézary Syndrome treated with Mogamulizumab and hematopoietic cell transplantationGentiana Elena Trotta, Giulia Ciangola, Ilaria Cerroni, et al.Transplantation|March 7, 2008
B-cell concentration in the apheretic product predicts acute graft-versus-host disease and treatment-related mortality of allogeneic peripheral blood stem cell transplantationAnna P Iori, Giovanni F Torelli, Maria S De Propris, et al.Transfusion|June 14, 2017
The Rome Transplant Network model compared to the Italian Bone Marrow Donor Registry activity for unrelated donor search process and transplant efficiency for hematologic malignancyAlessandra Picardi, William Arcese, Simona Pollichieni, et al.Blood|May 24, 2008
WHO classification and WPSS predict posttransplantation outcome in patients with myelodysplastic syndrome: a study from the Gruppo Italiano Trapianto di Midollo Osseo (GITMO)Emilio Paolo Alessandrino, Matteo Giovanni Della Porta, Andrea Bacigalupo, et al.Blood|November 21, 2012
Haploidentical, unmanipulated, G-CSF-primed bone marrow transplantation for patients with high-risk hematologic malignanciesPaolo Di Bartolomeo, Stella Santarone, Gottardo De Angelis, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 9, 2008
Toward optimization of postremission therapy for residual disease-positive patients with acute myeloid leukemiaLuca Maurillo, Francesco Buccisano, Maria Ilaria Del Principe, et al.American Journal of Hematology|November 8, 2014
Minimal residual disease as biomarker for optimal biologic dosing of ARA-C in patients with acute myeloid leukemiaLuca Maurillo, Francesco Buccisano, Alfonso Piciocchi, et al.Current Research in Translational Medicine|January 26, 2024
Overlapping features of hepatic complications after hematopoietic cell transplantation in a rare T-cell lymphoma: A clinical challengeAndrea Nunzi, Giulia Ciangola, Ilaria Cerroni, et al.Pageof 5